Reverse DCF

What growth rate is priced into Xylem Inc (XYL)?

At the current market price of $122.25, a reverse DCF implies Xylem Inc (XYL) must grow revenue about 13.7% per year for the next decade (25.9% in year one) to be worth what it trades for — holding margins, taxes, reinvestment, and the discount rate fixed at the model's baseline assumptions.

Market price

$122.25

Implied growth (yr 1)

25.9%

Implied 10-yr CAGR

13.7%

Run the live reverse DCF with your own assumptions →

Xylem Inc (XYL) reverse DCF FAQ

What revenue growth rate is priced into Xylem Inc (XYL)?

At the current market price of $122.25, a reverse DCF implies Xylem Inc's revenue must grow about 13.7% per year for the next ten years (starting at 25.9% in year one) to justify the price — holding margins, taxes, reinvestment, and the discount rate at the model's baseline assumptions.

What is a reverse DCF?

A regular DCF turns growth assumptions into a fair value. A reverse DCF inverts that: it holds every other assumption fixed and solves for the single revenue-growth path that makes intrinsic value equal the current market price. The result is the growth the market is already paying for — a hurdle you can judge the business against.

How does the implied growth compare with the model's own XYL forecast?

The forward DCF for Xylem Inc estimates a fair value of $62.88 per share, implying XYL is overvalued at the $122.25 market price. If the market-implied growth is well above what the forward model assumes, the price embeds more optimism than the fundamentals-anchored forecast — and vice versa.

How this XYL implied growth is solved

The engine takes the same 10-year DCF used for the Xylem Inc fair-value estimate — margins converging to Damodaran industry benchmarks, year-by-year WACC, a reinvestment rate tied to sales-to-capital efficiency — and inverts it: instead of projecting growth to get a value, it bisects on the starting revenue-growth rate, re-running the valuation until intrinsic value matches the market price. The implied path follows the same moat-scored convergence toward the 2% terminal growth rate that the forward model uses.

The interactive version lets you change what is held fixed — margins, convergence timing, industry benchmarks — and overlays the market-implied growth path on your own editable forecast, so you can see exactly where your expectations and the market's diverge.

The implied growth re-solves when Xylem Inc files a new quarterly or annual report. For educational/informational purposes only — not investment advice. Last solved 2026-07-28.